OLD National Bancorp IN Boosts Position in Roche Holding AG (OTCMKTS:RHHBY)

OLD National Bancorp IN raised its stake in Roche Holding AG (OTCMKTS:RHHBY) by 3.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 265,242 shares of the company’s stock after buying an additional 8,146 shares during the period. OLD National Bancorp IN’s holdings in Roche were worth $9,206,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also added to or reduced their stakes in the stock. AlphaMark Advisors LLC bought a new position in Roche during the 1st quarter worth about $34,000. Wetzel Investment Advisors Inc. bought a new position in Roche in the fourth quarter worth approximately $53,000. First Horizon Advisors Inc. lifted its holdings in Roche by 19.8% during the fourth quarter. First Horizon Advisors Inc. now owns 2,066 shares of the company’s stock worth $75,000 after buying an additional 342 shares during the period. GAMMA Investing LLC bought a new stake in Roche during the 4th quarter valued at $146,000. Finally, Waldron Private Wealth LLC purchased a new position in shares of Roche in the 4th quarter valued at $294,000.

Analyst Upgrades and Downgrades

Several research firms have issued reports on RHHBY. The Goldman Sachs Group started coverage on shares of Roche in a report on Thursday, May 30th. They issued a “sell” rating on the stock. Deutsche Bank Aktiengesellschaft raised Roche from a “sell” rating to a “hold” rating in a research report on Friday, May 17th. Two investment analysts have rated the stock with a sell rating and five have given a hold rating to the company. According to data from MarketBeat.com, Roche presently has an average rating of “Hold” and an average price target of $40.00.

Roche Stock Up 0.9 %

Roche stock traded up $0.35 during trading on Friday, reaching $40.18. The company had a trading volume of 550,250 shares, compared to its average volume of 2,429,395. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.35 and a quick ratio of 1.04. The firm’s 50-day simple moving average is $36.37 and its 200 day simple moving average is $33.56. Roche Holding AG has a 1-year low of $29.20 and a 1-year high of $41.15.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.